Stay updated on Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.2 to v3.5.3, indicating a version/release change to the ClinicalTrials.gov site interface rather than a modification to the study content.
    Difference
    0.1%
    Check dated 2026-04-24T17:10:04.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:52:48.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-19T19:40:43.000Z thumbnail image
  5. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, a routine system update with no user-facing changes to content or studies.
    Difference
    0.1%
    Check dated 2026-02-12T01:40:39.000Z thumbnail image
  6. Check
    85 days ago
    Change Detected
    Summary
    Minor system update: Revision changed from v3.4.0 to v3.4.1 with no visible changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:09:34.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    These changes are cosmetic UI and metadata updates that do not affect study content, enrollment, or results. Updates include showing the glossary toggle, capitalization fixes for QC-related fields, and the addition of 'No FEAR Act Data' with revision 'v3.4.0' replacing prior labels.
    Difference
    0.2%
    Check dated 2026-01-28T20:28:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial page.